ArticleBreast cancer research and treatment2015

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

Brian Leyland-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.